Biochemical factors in the lens opacities. Case-control study. The Lens Opacities Case-Control Study Group

M. C. Leske, S. Y. Wu, L. Hyman, R. Sperduto, B. Underwood, L. T. Chylack, R. C. Milton, S. Srivastava and N. Ansari
Department of Preventive Medicine, State University of New York at Stony Brook, USA.

OBJECTIVE: To evaluate associations with biochemical indicators of nutritional and other risk factors in the Lens Opacities Case-Control Study. DESIGN: Case-control study. SETTING AND PARTICIPANTS: The Lens Opacities Case-Control Study determined risk factors for cortical, nuclear, and posterior subcapsular opacities among 1380 participants aged 40 to 79 years. DATA COLLECTION: Vitamin E, selenium, and biochemistry profile determinations were performed on all patients; red blood cell enzymes and amino acids were measured in systematic samples of about 25% of the Lens Opacities Case-Control Study population. OUTCOME: Laboratory test values in cases and controls were compared and expressed as odds ratios and 95% confidence intervals. RESULTS: In polychotomous logistic regression analyses controlling for age and sex, the risk of opacities was reduced to less than one half in persons with higher levels of vitamin E (odds ratio, 0.44 for nuclear opacities), albumin-globulin ratio (odds ratio, 0.41 for mixed opacities), or iron (odds ratio, 0.43 for cortical opacities); higher uric acid levels increased risk (odds ratio, 1.74 for mixed opacities). Persons with opacities were twice as likely to have high glutathione reductase activity (with flavin adenine dinucleotide), which suggests low riboflavin status (odds ratio, 2.13). Most odds ratios for amino acids were under unity and were significantly decreased for glycine (0.36) and aspartic acid (0.31). CONCLUSIONS: Lens opacities were associated with lower levels of riboflavin, vitamin E, iron, and protein nutritional status. Higher levels of uric acid increased risk of mixed opacities. The findings for riboflavin, vitamin E, iron, and uric acid are compatible with the dietary intake and medical history results of the Lens Opacities Case-Control Study.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India
Gritz et al.
Br. J. Ophthalmol. 2006;90:847-851.
ABSTRACT | FULL TEXT  

Statin Use and Incident Nuclear Cataract
Klein et al.
JAMA 2006;295:2752-2758.
ABSTRACT | FULL TEXT  

Long-term Nutrient Intake and 5-Year Change in Nuclear Lens Opacities
Jacques et al.
Arch Ophthalmol 2005;123:517-526.
ABSTRACT | FULL TEXT  

Albumin and Transthyretin as Risk Factors for Cataract: The POLA Study
Delcourt et al.
Arch Ophthalmol 2005;123:225-232.
ABSTRACT | FULL TEXT  

Low Vitamin E Level as a Subliminal Risk Factor in a Rat Model of Prednisolone-Induced Cataract
Kojima et al.
IOVS 2002;43:1116-1120.
ABSTRACT | FULL TEXT  

Long-term intake of vitamins and carotenoids and odds of early age-related cortical and posterior subcapsular lens opacities
Taylor et al.
Am. J. Clin. Nutr. 2002;75:540-549.
ABSTRACT | FULL TEXT  

A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss: AREDS Report No. 9
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2001;119:1439-1452.
ABSTRACT | FULL TEXT  

Relations of body fat distribution and height with cataract in men
Schaumberg et al.
Am. J. Clin. Nutr. 2000;72:1495-1502.
ABSTRACT | FULL TEXT  

Serum carotenoids and tocopherols and incidence of age-related nuclear cataract
Lyle et al.
Am. J. Clin. Nutr. 1999;69:272-277.
ABSTRACT | FULL TEXT